` CNADF (CanadaBis Capital Inc) vs S&P 500 Comparison - Alpha Spread
Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

C
CNADF
vs
S&P 500

Over the past 12 months, CNADF has underperformed S&P 500, delivering a return of -62% compared to the S&P 500's +12% growth.

Back to CNADF Analysis

Stocks Performance
CNADF vs S&P 500

Loading
CNADF
S&P 500
Add Stock
www.alphaspread.com
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
CNADF vs S&P 500

Performance Gap Between CNADF and GSPC
HIDDEN
Show

Performance By Year
CNADF vs S&P 500

Loading
CNADF
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
CanadaBis Capital Inc vs Peers

S&P 500
CNADF
JEF
JNJ
4312
Add Stock
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

CanadaBis Capital Inc
Glance View

Market Cap
2.8m USD
Industry
Pharmaceuticals

CanadaBis Capital Inc. is a capital pool company, which engages in the identification and evaluation of assets or a business. The company is headquartered in Rocky Mountain House, Alberta. The company went IPO on 2017-03-08. The Company’s segments include Wholesale, Retail, and Extraction and Tolling. The Wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards that are subsequently sold to end consumers. The Retail segment involves in the sale of cannabis and cannabis-related products to end consumers on premise owned and operated by the Company. The Extraction and Tolling segment provides cannabinoid extraction services to other licensed producers. The Company’s subsidiaries include Stigma Pharmaceuticals Inc., 1998643 Alberta Ltd, Full Spectrum Labs Ltd, 2103157 Alberta Ltd. and Goldstream Cannabis Inc.

CNADF Intrinsic Value
HIDDEN
Show
What is Intrinsic Value?
Back to Top
ALPHA SPREAD
Follow us
Join more than 318,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.